November 22, 2017 7:41 PM ET

Pharmaceuticals

Company Overview of The Medicines Company

Executive Profile

Armin M. Kessler

Independent Director, The Medicines Company
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 organization across 9 different industries.

See Board Relationships
79$317,525

Background

Mr. Armin M. Kessler served as the Chief Operating Officer of Hoffman-La Roche from 1990 to 1995. Mr. Kessler is an experienced global pharmaceutical and biotech industry Executive. From 1983 to 1995, he held several senior positions at Hoffman-La Roche, including Head of the Pharmaceutical Division, Head of the Diagnostic Division with worldwide responsibility for pharmaceuticals, diagnostics, vitamins and chemicals and Managing Director of Roche U.K. He served as President ...

Corporate Headquarters

8 Sylvan Way
Parsippany, New Jersey 07054

United States

Phone: 973-290-6000
Fax: 973-656-9898

Board Members Memberships

Director
1998-Present
Independent Director

Education

JD 1971
Seton Hall University
BS 1959
University of Cape Town
Honorary Doctorate 1993
University of Pretoria
BS 1957
University of Pretoria

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$62,500
Total Calculated Compensation$317,525
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Douglas A. Michels Chief Executive Officer, President and Director
OraSure Technologies, Inc.
$612.3K
John Dawson CEO & Executive Director
Oxford BioMedica PLC
$553.0K
Yongfeng Zhang Ph.D.Chief Executive Officer, Chief Science Officer and Director
Amphastar Pharmaceuticals, Inc.
$1.5M
Craig A. Wheeler Chief Executive Officer, President and Executive Director
Momenta Pharmaceuticals, Inc.
$689.2K
Rick E. Winningham Chairman & CEO
Theravance Biopharma, Inc.
$1.1M
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact The Medicines Company, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.